Skip to content

Myocardial Injury After Elective Coronary Stenting

Identification of Patients at Higher Risk for Myocardial Injury or Type 4a Infarction Following Elective Coronary Artery Stenting

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01986621
Enrollment
530
Registered
2013-11-18
Start date
2014-04-30
Completion date
2015-07-31
Last updated
2018-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

Percutaneous Coronary Intervention, Cardiac troponin, Antiplatelet therapy

Brief summary

This pilot study aims to identify patients at moderate to high risk for peri-procedural (type 4) myocardial infarction or injury after after undergoing an elective coronary intervention (PCI) as measured by high sensitivity troponin T, who might benefit from more potent antiplatelet therapy.

Interventions

None listed

Sponsors

AstraZeneca
CollaboratorINDUSTRY
University Hospital Heidelberg
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Stable or unknown coronary artery disease (CAD) * Elective coronary intervention * Minimum age of 18

Exclusion criteria

* Present acute coronary syndrome (ACS) * Age under 18 * Pregnancy * Any additional invasive intervention with potential myocardial injury * Non ACS conditions responsible for elevation of cardiac troponin, such as acute pulmonary artery embolism, myocarditis or tachycardia.

Design outcomes

Primary

MeasureTime frame
Postprocedural myocardial infarction (type 4a) or injuryup to 72 hours after procedure

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026